Business, energy, technology, markets and global industry news from Business News Today

EXACT

PharmaDeviceNews EXACT
A representative image illustrating Teva Pharmaceutical Industries’ ecopipam program as the FDA grants Priority Review for the investigational pediatric Tourette syndrome treatment following positive Phase 3 relapse-prevention data.
Pharma & Biotech

Neurogene reports rapid MECP2 expression and new gene regulation data for NGN-401 in Rett syndrome

Neurogene reports rapid MECP2 expression and new regulation data for NGN-401, strengthening its Rett syndrome research ahead of 2027 results.

Read More
Mezzion’s investigational drug udenafil has reduced kidney cyst burden in an ADPKD animal study, strengthening the scientific rationale for the company’s planned Phase 2b clinical programme. Representative image.
Pharma & Biotech

What will Eloxx Pharmaceuticals’ EXACT trial reveal about exaluren in Alport syndrome?

Eloxx starts Phase 2b testing of exaluren in nonsense mutation Alport syndrome, with a 16-week biomarker readout expected in mid-2027.

Read More